Bućin D
Blood Bank and Tissue Typing Laboratory, University Hospital, Lund, Sweden.
Exp Clin Immunogenet. 1986;3(3):138-44.
The combined effect on 2-year primary kidney allograft survival of pretransplant blood transfusion, HLA-DR matching, HLA-A matching, HLA-B matching and other factors was analyzed in 116 azathioprine- and prednisolone-treated patients. The results show an hitherto unreported, statistically significant association between incompatibility for HLA-A antigens and enhanced graft survival in transfused recipients of transplants mismatched for HLA-DR (p = 0.005) and for HLA-B (p = 0.008). As expected, compatibility for HLA-B antigens was significantly associated with increased graft survival in transfused recipients of both HLA-DR compatible (p = 0.004) and HLA-DR incompatible (p = 0.01) grafts. If confirmed, the findings foreshadow new aspects of HLA matching in kidney transplantation and might explain the beneficial effect of blood transfusion on renal allograft survival.
对116例接受硫唑嘌呤和泼尼松龙治疗的患者,分析了移植前输血、HLA-DR配型、HLA-A配型、HLA-B配型及其他因素对2年原发性肾移植存活率的综合影响。结果显示,在HLA-DR(p = 0.005)和HLA-B(p = 0.008)配型不相合的输血受者中,HLA-A抗原不相合与移植存活率提高之间存在迄今未报道的统计学显著关联。正如预期的那样,在HLA-DR相合(p = 0.004)和HLA-DR不相合(p = 0.01)的移植输血受者中,HLA-B抗原相合均与移植存活率提高显著相关。如果得到证实,这些发现预示着肾移植中HLA配型的新方面,并可能解释输血对肾移植存活的有益作用。